Lupin recalls 51k bottles of generic drug due to defective containers in US
Lupin initiated the Class II nationwide (US) voluntary recall on May 8. (Representational Image) 2 min read Last Updated :
Continue reading
Tag: Food and Drug Administration
Sun Pharma, Lupin recall drugs in US market over manufacturing issues: FDA
Princeton-based Sun Pharmaceutical Industries Inc, a unit of the company, is recalling the affected lot that was produced at the
Continue reading
Granules India get US FDA’s approval for another ANDA capsule, shares dip
Granules India Limited announced that the USFDA approved its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules USP,
Continue reading
Domestic drug makers Sun Pharma, Alembic recall drugs in US market
Domestic drug makers Sun Pharma and Alembic are recalling products in the US market due to manufacturing issues, according
Continue reading